Darbepoetin Alfa With or Without Intravenous (IV) Iron

NCT00401544 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Non-Myeloid Malignancies

Interventions

DRUG: darbepoetin alfa
DRUG: IV iron dextran

Sponsor

Amgen